384 related articles for article (PubMed ID: 10953335)
1. Blockade of cyclooxygenase-2 inhibits proliferation and induces apoptosis in human pancreatic cancer cells.
Ding XZ; Tong WG; Adrian TE
Anticancer Res; 2000; 20(4):2625-31. PubMed ID: 10953335
[TBL] [Abstract][Full Text] [Related]
2. The effect of selective cyclooxygenase inhibitors on intestinal epithelial cell mitogenesis.
Erickson BA; Longo WE; Panesar N; Mazuski JE; Kaminski DL
J Surg Res; 1999 Jan; 81(1):101-7. PubMed ID: 9889067
[TBL] [Abstract][Full Text] [Related]
3. NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells.
Liu XH; Yao S; Kirschenbaum A; Levine AC
Cancer Res; 1998 Oct; 58(19):4245-9. PubMed ID: 9766645
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells.
Sun Y; Tang XM; Half E; Kuo MT; Sinicrope FA
Cancer Res; 2002 Nov; 62(21):6323-8. PubMed ID: 12414664
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells.
Souza RF; Shewmake K; Beer DG; Cryer B; Spechler SJ
Cancer Res; 2000 Oct; 60(20):5767-72. PubMed ID: 11059772
[TBL] [Abstract][Full Text] [Related]
6. [Effects of selective cyclooxygenase-2 inhibitor NS-398 on 5-fluorouracil chemotherapy and progression of colon cells: an experimental study].
Zhang YC; Wang S; Zhang H; Ye YJ; Liang B; Cui ZR
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):583-6. PubMed ID: 15144595
[TBL] [Abstract][Full Text] [Related]
7. Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398.
Bae SH; Jung ES; Park YM; Kim BS; Kim BK; Kim DG; Ryu WS
Clin Cancer Res; 2001 May; 7(5):1410-8. PubMed ID: 11350912
[TBL] [Abstract][Full Text] [Related]
8. The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis.
Minter HA; Eveson JW; Huntley S; Elder DJ; Hague A
Clin Cancer Res; 2003 May; 9(5):1885-97. PubMed ID: 12738747
[TBL] [Abstract][Full Text] [Related]
9. NS-398 inhibits tumor growth and liver metastasis of colon cancer through induction of apoptosis and suppression of the plasminogen activation system in a mouse model.
Nishikawa M; Stapleton PP; Freeman TA; Gaughan JP; Matsuda T; Daly JM
J Am Coll Surg; 2004 Sep; 199(3):428-35. PubMed ID: 15325613
[TBL] [Abstract][Full Text] [Related]
10. Specific COX-2 inhibitor, NS-398, suppresses cellular proliferation and induces apoptosis in human hepatocellular carcinoma cells.
Cheng AS; Chan HL; Leung WK; Wong N; Johnson PJ; Sung JJ
Int J Oncol; 2003 Jul; 23(1):113-9. PubMed ID: 12792783
[TBL] [Abstract][Full Text] [Related]
11. Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs.
Molina MA; Sitja-Arnau M; Lemoine MG; Frazier ML; Sinicrope FA
Cancer Res; 1999 Sep; 59(17):4356-62. PubMed ID: 10485483
[TBL] [Abstract][Full Text] [Related]
12. Lipoxygenase inhibition induced apoptosis, morphological changes, and carbonic anhydrase expression in human pancreatic cancer cells.
Ding XZ; Kuszynski CA; El-Metwally TH; Adrian TE
Biochem Biophys Res Commun; 1999 Dec; 266(2):392-9. PubMed ID: 10600514
[TBL] [Abstract][Full Text] [Related]
13. Inhibited proliferation of cyclooxygenase-2 expressing human hepatoma cells by NS-398, a selective COX-2 inhibitor.
Hu KQ; Yu CH; Mineyama Y; McCracken JD; Hillebrand DJ; Hasan M
Int J Oncol; 2003 Apr; 22(4):757-63. PubMed ID: 12632065
[TBL] [Abstract][Full Text] [Related]
14. Increased cyclooxygenase-2 expression in human squamous cell carcinomas of the head and neck and inhibition of proliferation by nonsteroidal anti-inflammatory drugs.
Lee DW; Sung MW; Park SW; Seong WJ; Roh JL; Park B; Heo DS; Kim KH
Anticancer Res; 2002; 22(4):2089-96. PubMed ID: 12174888
[TBL] [Abstract][Full Text] [Related]
15. A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2.
Pyo H; Choy H; Amorino GP; Kim JS; Cao Q; Hercules SK; DuBois RN
Clin Cancer Res; 2001 Oct; 7(10):2998-3005. PubMed ID: 11595687
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines.
Hashitani S; Urade M; Nishimura N; Maeda T; Takaoka K; Noguchi K; Sakurai K
Int J Oncol; 2003 Sep; 23(3):665-72. PubMed ID: 12888902
[TBL] [Abstract][Full Text] [Related]
17. Expression of cyclooxygenase-2 (COX-2) in human esophageal cancer and in vitro inhibition by a specific COX-2 inhibitor, NS-398.
Yu HP; Shi LY; Lu WH; Su YH; Li YY; Xu SQ
J Gastroenterol Hepatol; 2004 Jun; 19(6):638-42. PubMed ID: 15151617
[TBL] [Abstract][Full Text] [Related]
18. A selective cyclooxygenase-2 inhibitor, NS398, inhibits cell growth and induces cell cycle arrest in the G2/M phase in human esophageal squamous cell carcinoma cells.
Kase S; Osaki M; Honjo S; Takeda A; Adachi K; Araki K; Ito H
J Exp Clin Cancer Res; 2004 Jun; 23(2):301-7. PubMed ID: 15354416
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines.
Hida T; Kozaki K; Muramatsu H; Masuda A; Shimizu S; Mitsudomi T; Sugiura T; Ogawa M; Takahashi T
Clin Cancer Res; 2000 May; 6(5):2006-11. PubMed ID: 10815926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
